A
Abingworth Portfolio holdings
AUM
$307M
This Quarter Return
+27.68%
1 Year Return
+93.6%
3 Year Return
+207.29%
5 Year Return
+452.78%
10 Year Return
–
AUM
$235M
AUM Growth
+$235M
(-33%)
Cap. Flow
-$156M
Cap. Flow
% of AUM
-66.39%
Top 10 Holdings %
Top 10 Hldgs %
95.58%
Holding
18
New
2
Increased
–
Reduced
4
Closed
1
Top Buys
1 |
CCXI
ChemoCentryx, Inc.
CCXI
|
$824K |
2 |
Salarius Pharmaceuticals
SLRX
|
$200K |
Top Sells
1 |
RNA
PROSENSA HLDGS N V ORD SHS (NLD)
RNA
|
$117M |
2 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$22.1M |
3 |
Supernus Pharmaceuticals
SUPN
|
$6.96M |
4 |
CEMP
Cempra, Inc.
CEMP
|
$6.52M |
5 |
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
|
$5.03M |
Sector Composition
1 | Healthcare | 77.25% |